Klonopin: Package Insert and Label Information (Page 5 of 5)

PRINCIPAL DISPLAY PANEL — 0.5 mg Tablet Bottle Label

NDC 61269-605-10

Klonopin®
(clonazepam)
CIV

0.5 mg

Each tablet contains 0.5 mg clonazepam.

ATTENTION PHARMACIST: Dispense the
accompanying Medication Guide to each patient.


For additional Medication Guides visitwww.h2-pharma.com/products/klonopin/medicationguide.

100 tablets

Rx only

CHEPLAPHARM Arzneimittel

PRINCIPAL DISPLAY PANEL -- 0.5 mg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 1 mg Tablet Bottle Label

NDC 61269-610-10

Klonopin®
(clonazepam)
CIV

1 mg

Each tablet contains 1 mg clonazepam.

ATTENTION PHARMACIST: Dispense the
accompanying Medication Guide to each patient.


For additional Medication Guides visitwww.h2-pharma.com/products/klonopin/medicationguide.

100 tablets

Rx only

CHEPLAPHARM Arzneimittel

PRINCIPAL DISPLAY PANEL -- 1 mg Tablet Bottle Label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 2 mg Tablet Bottle Label

NDC 61269-620-10

Klonopin®
(clonazepam)
CIV

2 mg

Each tablet contains 2 mg clonazepam.

ATTENTION PHARMACIST: Dispense the
accompanying Medication Guide to each patient.


For additional Medication Guides visitwww.h2-pharma.com/products/klonopin/medicationguide.

100 tablets

Rx only

CHEPLAPHARM Arzneimittel

PRINCIPAL DISPLAY PANEL -- 2 mg Tablet Bottle Label
(click image for full-size original)
KLONOPIN clonazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:61269-605
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM 0.5 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
STARCH, CORN
FD&C YELLOW NO. 6
Product Characteristics
Color ORANGE Score 2 pieces
Shape ROUND Size 9mm
Flavor Imprint Code 1;2;KLONOPIN
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:61269-605-10 100 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017533 06/02/1975
KLONOPIN clonazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:61269-610
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM 1 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
STARCH, CORN
FD&C BLUE NO. 1
FD&C BLUE NO. 2
Product Characteristics
Color BLUE Score no score
Shape ROUND Size 9mm
Flavor Imprint Code 1;KLONOPIN
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:61269-610-10 100 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017533 06/02/1975
KLONOPIN clonazepam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:61269-620
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLONAZEPAM (CLONAZEPAM) CLONAZEPAM 2 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE, UNSPECIFIED FORM
MAGNESIUM STEARATE
MICROCRYSTALLINE CELLULOSE
STARCH, CORN
Product Characteristics
Color WHITE Score no score
Shape ROUND Size 9mm
Flavor Imprint Code 2;KLONOPIN
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:61269-620-10 100 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA017533 06/02/1975
Labeler — H2-Pharma, LLC (028473634)
Registrant — CHEPLAPHARM Arzneimittel GmbH (329834878)

Revised: 01/2023 H2-Pharma, LLC

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.